Fulgent Genetics, Inc.
FLGT
$21.77
$0.3751.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.35% | -3.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.35% | -3.61% | |||
| Cost of Revenue | 4.99% | 1.70% | |||
| Gross Profit | 21.48% | -11.00% | |||
| SG&A Expenses | 14.58% | -0.36% | |||
| Depreciation & Amortization | 0.00% | -0.10% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.86% | 0.98% | |||
| Operating Income | 0.41% | -22.68% | |||
| Income Before Tax | -83.56% | -45.72% | |||
| Income Tax Expenses | -1,385.80% | 109.49% | |||
| Earnings from Continuing Operations | -61.83% | -92.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -18.97% | 22.19% | |||
| Net Income | -64.41% | -95.82% | |||
| EBIT | 0.41% | -22.68% | |||
| EBITDA | 1.56% | -39.56% | |||
| EPS Basic | -65.94% | -94.69% | |||
| Normalized Basic EPS | -0.75% | -46.37% | |||
| EPS Diluted | -65.94% | -93.78% | |||
| Normalized Diluted EPS | -0.75% | -46.37% | |||
| Average Basic Shares Outstanding | -0.93% | 0.59% | |||
| Average Diluted Shares Outstanding | -0.93% | 0.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||